Literature DB >> 26581496

Intrapulmonary Castleman's Disease Pretending to Be a Lung Cancer-Work Up of an Intrapulmonary Tumour.

Benedikt Haager1, Gian Kayser, Severin Schmid, Bernward Passlick, Sebastian Wiesemann.   

Abstract

A 24 year old male presented with a history of recurrent bronchopulmonal infections. Chest computed tomography was performed, revealing a right central mass. In the following bronchoscopy and ultrasound guided needle aspiration of the tumour no specific diagnosis could be obtained. Due to the central location of the tumour thoracotomy and middle lobe resection was performed. Histopathological analysis revealed an intrapulmonary, subpleural located Morbus Castleman of the hyaline-vascular type.Castleman's disease is a very rare disorder of the lymphatic tissue that is differentiated into two clinical subtypes. The localized type presents histologically almost always as the hyaline-vascular form. Findings have been reported in mediastinal lymph nodes, the abdomen and peripheral lymphnodes. Intrapulmonary development is very rare and only 9 cases have previously been described in literature.On the other hand the multicentric type accounts for approximately 10%-15% of cases and histologically usually presents as the plasma cell variant. It is accompanied by fatigue and general weakness and often requires systemic steroid or chemotherapy.The localized type develops less clinical symptoms and is curable by complete surgical resection.

Entities:  

Mesh:

Year:  2015        PMID: 26581496      PMCID: PMC5045854          DOI: 10.5761/atcs.cr.15-00216

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  12 in total

1.  Intrapulmonary-located Castleman's disease, which was surgically resected without pulmonary resection.

Authors:  Gulsah Gunluoglu; Aysun Olcmen; Sinem Nedime Sokucu; Hasan Akin; Ibrahim Dincer
Journal:  Ann Thorac Cardiovasc Surg       Date:  2011-07-27       Impact factor: 1.520

2.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

Review 3.  Multicentric Castleman's disease.

Authors:  B A Peterson; G Frizzera
Journal:  Semin Oncol       Date:  1993-12       Impact factor: 4.929

4.  Pathologic quiz case 2. Castleman disease (giant lymph node hyperplasia).

Authors:  K Gangopadhyay; Z Z Mahasin; H Kfoury
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-10

Review 5.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

6.  Characteristics of Castleman's disease in Peru.

Authors:  Salim Mohanna; Juvenal Sanchez; Juan Carlos Ferrufino; Francisco Bravo; Eduardo Gotuzzo
Journal:  Eur J Intern Med       Date:  2006-05       Impact factor: 4.487

7.  Castleman's disease: an intrapulmonary form with intrafissural development.

Authors:  Hajer Racil; Sana Cheikh Rouhou; Olfa Ismail; Saoussen Hantous-Zannad; Nawel Chaouch; Mourad Zarrouk; Belhassen Smati; Faouzi Mezni; Abdellatif Chabbou
Journal:  ScientificWorldJournal       Date:  2009-09-14

Review 8.  Isolated intrapulmonary Castleman's disease: a case report, review of the literature.

Authors:  Aydin Nadir; Necmettin Colak; Asli Koktener; Umran Yildirim
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

9.  Multicentric giant lymph node hyperplasia.

Authors:  A R Gaba; R S Stein; D L Sweet; D Variakojis
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

10.  Unicentric Castleman's Disease Arising from an Intrapulmonary Lymph Node.

Authors:  Hideki Ota; Hideki Kawai; Tsubasa Matsuo
Journal:  Case Rep Surg       Date:  2013-06-10
View more
  3 in total

Review 1.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

2.  Tumor enucleation for Castleman's disease in the pulmonary hilum: a case report.

Authors:  Masaya Aoki; Go Kamimura; Tadashi Umehara; Aya Harada Takeda; Yui Watanabe; Koki Maeda; Toshiyuki Nagata; Tsunayuki Otsuka; Masami Sato
Journal:  Surg Case Rep       Date:  2019-06-10

3.  Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.

Authors:  Midori Filiz Nishimura; Takuro Igawa; Yuka Gion; Sakura Tomita; Dai Inoue; Akira Izumozaki; Yoshifumi Ubara; Yoshito Nishimura; Tadashi Yoshino; Yasuharu Sato
Journal:  J Pers Med       Date:  2020-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.